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A highly contagious coronavirus disease 2019 
(COVID-19) is caused by Severe Acute Respiratory 
Syndrome Coronavirus 2 (SARS-CoV-2), which 
was first identified in Wuhan, China in December 
2019 (1). The virus primarily affects the 
respiratory system of human beings and results in 
the symptoms of headache, fever, dry cough, sore 
throat, shortness of breath and fatigue with 
abnormal chest computed tomography (CT) scan. 
In some cases, nasal sputum discharge and 
diarrhea have been also reported (2-4). Up to the 
26th of April 2020, more than three million 
laboratory confirmed cases of COVID-19 have 
been recorded worldwide with more than 220,000 
confirmed deaths (5). 
In the Kurdistan region of Iraq, the first case of 
laboratory confirmed COVID-19 was recorded in 
March 1st, 2020 in Sulaymaniyah province (6-8).  
Figure 1 shows the number of mortality and 
morbidity cases in the four different cities of 
Kurdistan region of Iraq; By May 2nd, 2020, the 
number of COVID-19 cases rose to 387 people, 
with 5 deaths, and 330 recovered patients in 
Kurdistan region (9).  
Considering the geographical location of the 
Kurdistan region of Iraq to the highly infected 
COVID-19 neighboring countries of Iran and 
Turkey (figure 2) and also the reproduction 
number (R0) of the disease, it was expected that 
the disease will spread faster and would infect a 
greater number of people in the region (10). In Iran 
and Turkey, the mortality to the morbidity 
number were 6091/95646 and 3258/122392 
respectively up to May 2nd, 2020 (11). In addition, 
COVID-19 is highly contagious and having the 
reproduction number (R0) of 3.28, meaning every 
single infected person will infect about 3.28 
others, on average (10).   
Although the Kurdistan regional government may 
have played an important role in controlling the 
spread of the disease by applying early travel 
restriction, shutting down airports, schools and 
other public places and imposing a curfew to 
enforce social distancing. It is also expected that 
low rate of morbidity and mortality in the region 
could relate to the immunity of the resident of the 
region against the disease. Particularly, the 
majority (>75%) of the confirmed COVID-19 cases 
in Kurdistan region of Iraq were asymptomatic (8). 
In addition, all the five recorded deaths had 
underlying health conditions, and only two of 
 
Figure 1: Number of mortality and morbidity cases in the 
four different cities of Kurdistan region of Iraq 
 
 
Figure 2: Location of the Kurdistan Region of Iraq to its 
highly infected COVID-19 countries of Iran and Turkey 
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them were hospitalized COVID-19 patient, the rest 
were confirmed to have died of COVID-19 base on 
post-mortem examination of the corpses. 
There are three hypotheses that proposed to 
explain low morbidity and mortality rate of the 
COVID-19 in the Kurdistan region of Iraq: first, the 
local strain of the SARS-CoV2 may be different, 
second, the Bacillus Calmette–Guérin (BCG) 
vaccination may have contributed in the immunity 
of the people (8). Lastly, the residents of the region 
may have already passed through herd immunity 
of COVID-19 before or during the outbreak.  
So far, three variant of the SARS-COV-2 have been 
recognized worldwide named A, B, and C clusters 
(12). Type A is an ancestral SARS-COV-2 and both 
type A and type C are found mainly in Europe, 
United States, and Australia. Type B, however, is 
the most common type in East Asia (12). Although 
the genome data of the SARS-COV2 of Kurdistan 
region is not available yet, it is unlikely the strain 
to be different at least from the neighboring 
countries of Iran and Turkey. Especially, majority 
of the positive cases of COVID-19 in Sulaymaniyah 
city were those people who visited or had a 
contact with those who visited Iran. The 
protective role of the BCG vaccination against 
COVID-19 and reducing mortality rate of the 
patient has already been proposed (8, 13). However, 
according to BCG World Atlas 
(http://www.bcgatlas.org/), Kurdistan region of 
Iraq, Iran and Turkey are among the countries that 
they have BCG vaccination policy since childhood 
(14). Therefore, it is unlikely that BCG vaccination 
protects the residents of the Kurdistan of Iraq 
against COVID-19, but do not protect the residents 
of Iran or Turkey. Lastly, the low morbidity and 
mortality rate of COVID-19 in the region is 
associated with having unidentified non-specific 
immunity by the population against the virus.  We 
hypothesize that herd immunity may have 
provided key protection against SARS-CoV-2.  
Perhaps, SARS-CoV-2 might have already spread 
undetected in this region. It was known to local 
residents of Kurdistan Region of Iraq that there 
was a severe form of “seasonal flu”-like disease in 
December, 2019 and January, 2020. Several 
people were hospitalized and some may have died 
from the disease without confirming the causative 
agent. Lack of advanced diagnostic techniques and 
symptoms similarity of COVID-19 with common 
flu might have resulted in the misidentification of 
the disease in the Kurdistan Region of Iraq. 
Moreover, the CT scan of the infected people 
showed a very severe and different form of the 
infection comparing to the seasonal flu (verbal 
communication with a local physician). 
Furthermore, a similar claim in France, although 
not scientifically backed, reported that the first 
case of COVID-19 dated back to mid or late of 
December, 2019 (15). 
To sum up, the mortality and morbidity of COVID-
19 are lower in Kurdistan region of Iraq compared 
to the neighboring and other countries around the 
world. Thus, we believe that undiagnosed 
outbreak of COVID-19 previously may have 
happened before declaring the pandemic. This 
resulted in silent herd immunity against the 
disease in the population of Kurdistan and this can 
be considered as a key protection mean against 
the disease in the region. 
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